Verily Life Sciences

See the following -

Pharma and Tech Giants Team Up to Design Devices That Can Hack Your Body’s Electrical Signals

Akshat Rathi | Nextgov | August 1, 2016

Electrical signals from the brain govern much of what goes on in the human body. Pharma and tech giants are spending big money to figure out how to hack these signals, a burgeoning field known as “bioelectronics.” GlaxoSmithKline and Verily Life Sciences, an Alphabet subsidiary, are investing more than $700 million over seven years to create a new company, Galvani Bioelectronics. The firm, 55 percent owned by GSK, will have one lab in Stevenage, U.K., and another in San Francisco...

Read More »

Verily launches clever new spoon That Compensates for Disabilities

Josh Baxt | MedCity News | December 4, 2016

People with physical disabilities face many challenges, such as difficulty eating, something many take for granted. But now Verily Life Sciences, formerly Google Life Sciences, has launched the Liftware Level, a handheld robotic device that compensates for erratic hand and arm movements, allowing people to eat without spilling. As part of the recent launch, the Huntington’s Disease Society of America (HDSA) and Teva Pharmaceuticals will be donating 1,000 Liftware Level Starter Kits to people who could benefit from the device...

Read More »

Where HIMSS Can Take Health 2.0

Andy Oram | EMR and HIPAA | March 16, 2017

I was quite privileged to talk to the leaders of Health 2.0, Dr. Indu Subaiya and Matthew Holt, in the busy days after their announced merger with HIMSS. I was revving to talk to them because the Health 2.0 events I have attended have always been stimulating and challenging. I wanted to make sure that after their incorporation into the HIMSS empire they would continue to push clinicians as well as technologists to re-evaluate their workflows, goals, and philosophies...

Read More »